Zkusit zdarma
Ashland Inc.

Ashland Inc.

ASH
Cena:
$ 57.21
+0.95 (1.69%)
Valuace
78
Růst
8
Zdraví
71
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

15:45 21-05-2026

NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

17:37 19-05-2026

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of invest...

Ashland Board appoints Bertrand Loy as new director

Ashland Board appoints Bertrand Loy as new director

7:00 18-05-2026

WILMINGTON, Del., May 18, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is announcing the appoin...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

0:00 15-05-2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH ...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

23:01 14-05-2026

NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

16:54 12-05-2026

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of invest...

Ashland board authorizes quarterly dividend

Ashland board authorizes quarterly dividend

17:01 05-05-2026

WILMINGTON, Del., May 05, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH...

ASH Q2 Earnings and Sales Miss on Weak Pricing, Intermediates Weakness

ASH Q2 Earnings and Sales Miss on Weak Pricing, Intermediates Weakness

9:20 04-05-2026

ASH posts weaker Q2 results with earnings and sales missing estimates despite gains in Personal Care...

Ashland Inc. (ASH) Q2 2026 Earnings Call Transcript

Ashland Inc. (ASH) Q2 2026 Earnings Call Transcript

16:51 29-04-2026

Ashland Inc. (ASH) Q2 2026 Earnings Call Transcript...

Ashland (ASH) Reports Q2 Earnings: What Key Metrics Have to Say

Ashland (ASH) Reports Q2 Earnings: What Key Metrics Have to Say

21:01 28-04-2026

The headline numbers for Ashland (ASH) give insight into how the company performed in the quarter en...

Ashland (ASH) Q2 Earnings and Revenues Miss Estimates

Ashland (ASH) Q2 Earnings and Revenues Miss Estimates

20:01 28-04-2026

Ashland (ASH) came out with quarterly earnings of $0.91 per share, missing the Zacks Consensus Estim...

Ashland reports second quarter fiscal 2026 results and updates full-year outlook

Ashland reports second quarter fiscal 2026 results and updates full-year outlook

17:01 28-04-2026

Sales of $482 million, up one percent from the prior-year quarter Income from continuing operations ...

Cwm LLC Sells 15,370 Shares of Ashland Inc. $ASH

Cwm LLC Sells 15,370 Shares of Ashland Inc. $ASH

4:07 23-04-2026

Cwm LLC cut its holdings in Ashland Inc. (NYSE: ASH) by 19.1% during the fourth quarter, according t...

Ashland (ASH) Reports Next Week: What to Expect

Ashland (ASH) Reports Next Week: What to Expect

11:01 21-04-2026

Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings...

Ashland sets date for second-quarter fiscal 2026 earnings release and conference call webcast

Ashland sets date for second-quarter fiscal 2026 earnings release and conference call webcast

17:01 15-04-2026

WILMINGTON, Del., April 15, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans ...

Massachusetts Financial Services Co. MA Lowers Stock Position in Ashland Inc. $ASH

Massachusetts Financial Services Co. MA Lowers Stock Position in Ashland Inc. $ASH

5:38 13-04-2026

Massachusetts Financial Services Co. MA reduced its stake in shares of Ashland Inc. (NYSE: ASH) by 4...

ASH Introduces Pricing Actions to Manage Market Volatility

ASH Introduces Pricing Actions to Manage Market Volatility

11:51 24-03-2026

Ashland rolls out pricing actions across segments to counter market volatility and cost pressures, w...

Ashland implements pricing actions across product portfolio in response to market volatility

Ashland implements pricing actions across product portfolio in response to market volatility

6:55 23-03-2026

Wilmington, Del., March 23, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is implementing pricin...

Ashland Inc. (ASH) Presents at Gabelli Funds Annual Specialty Chemicals Symposium Transcript

Ashland Inc. (ASH) Presents at Gabelli Funds Annual Specialty Chemicals Symposium Transcript

16:32 19-03-2026

Ashland Inc. (ASH) Presents at Gabelli Funds Annual Specialty Chemicals Symposium Transcript...

Ashland CFO to discuss current market environment at the Gabelli Funds' 17th Annual Specialty Chemicals Symposium

Ashland CFO to discuss current market environment at the Gabelli Funds' 17th Annual Specialty Chemicals Symposium

17:01 17-03-2026

WILMINGTON, Del., March 17, 2026 (GLOBE NEWSWIRE) -- William C....

close

ASHLAND AGRIMER™ ECO-COAT POLYMER SEED COATING FROM THE TRANSFORMED VEGETABLE OILS (TVO) PLATFORM RECEIVES APPROVAL FOR ALL FOOD AND NON-FOOD USES IN PESTICIDE FORMULATIONS INCLUDING FOR SALE IN THE U.S.

09-02-2026
ASHLAND POLYMER SEED COATING FROM THE TRANSFORMED VEGETABLE OILS (TVO) PLATFORM RECEIVES APPROVAL FO...
Více zde

ASHLAND REPORTS FIRST QUARTER FISCAL 2026 RESULTS AND NARROWS FULL-YEAR OUTLOOK

02-02-2026
SALES OF $386 MILLION, DOWN FIVE PERCENT FROM THE PRIOR-YEAR QUARTER PREVIOUSLY ANNOUNCED AVOCA DIVE...
Více zde

UNIVAR SOLUTIONS AND ASHLAND FORGE EXCLUSIVE PARTNERSHIP FOR CELLULOSE ETHERS IN FOOD AND BEVERAGE SECTOR THROUGHOUT EMEA

27-01-2026
EXPANDING ACCESS IN EMEA MARKETS TO MEET RISING DEMAND FOR FUNCTIONAL INGREDIENTS AND DRIVE INNOVATI...
Více zde

ASHLAND SETS DATE FOR FIRST-QUARTER FISCAL 2026 EARNINGS RELEASE AND CONFERENCE CALL WEBCAST

20-01-2026
WILMINGTON, DEL., JAN. 20, 2026 (GLOBE NEWSWIRE) -- ASHLAND INC. (NYSE: ASH) TODAY ANNOUNCED PLANS T...
Více zde

ASHLAND BOARD AUTHORIZES QUARTERLY DIVIDEND

19-01-2026
WILMINGTON, DEL., JAN. 19, 2026 (GLOBE NEWSWIRE) -- THE BOARD OF DIRECTORS OF ASHLAND INC. (NYSE: AS...
Více zde

INDEPENDENT STUDY PRESENTED AT AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING CONCLUDES REMESTEMCEL-L SUPERIOR TO RUXOLITINIB IN CLINICAL OUTCOMES AS TREATMENT FOR SR-AGVHD

11-12-2025
NEW YORK, DEC. 11, 2025 (GLOBE NEWSWIRE) -- MESOBLAST LIMITED (NASDAQ:MESO; ASX:MSB), GLOBAL LEADER ...
Více zde

OVER 20 STUDIES OF INNOCARE'S ORELABRUTINIB PRESENTED AT THE 67TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY (ASH)

09-12-2025
BEIJING, DEC. 09, 2025 (GLOBE NEWSWIRE) -- INNOCARE PHARMA (HKEX: 09969; SSE: 688428), A LEADING BIO...
Více zde

ASH 2025 | ASCENTAGE PHARMA PRESENTS FIRST DATASET FROM PHASE III POLARIS-1 STUDY OF OLVEREMBATINIB IN NEWLY DIAGNOSED PH+ ALL SHOWS A BEST MRD-NEGATIVITY CR RATE EXCEEDING 60%

08-12-2025
ROCKVILLE, MD. AND SUZHOU, CHINA, DEC. 08, 2025 (GLOBE NEWSWIRE) -- ASCENTAGE PHARMA GROUP INTERNATI...
Více zde

BRISTOL MYERS SQUIBB ADVANCES LYMPHOMA RESEARCH WITH NEW TARGETED PROTEIN DEGRADATION AND CELL THERAPY DATA AT ASH 2025

08-12-2025
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #ASH--BRISTOL MYERS SQUIBB ADVANCES LYMPHOMA RESEARCH WITH...
Více zde

AUTOLUS THERAPEUTICS PRESENTS UPDATED CLINICAL DATA FROM THE CARLYSLE TRIAL IN PATIENTS WITH SEVERE REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS AT THE AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING 2025

08-12-2025
AUTOLUS PRESENTED PRELIMINARY DATA FROM THE PHASE 1 CARLYSLE TRIAL IN PATIENTS WITH SEVERE REFRACTOR...
Více zde

CASI PHARMACEUTICALS ANNOUNCES RESULTS FROM CID-103 IMMUNE THROMBOCYTOPENIA STUDY AT THE 67TH AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING

08-12-2025
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS NEWSWIRE / DECEMBER 8, 2025 / CASI PHARMACEUTICALS, INC. (N...
Více zde

AUTOLUS THERAPEUTICS PRESENTS INITIAL CLINICAL DATA IN PEDIATRIC R/R B-ALL PATIENTS AND OTHER ONCOLOGY DATA AT THE AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING 2025

08-12-2025
OBE-CEL DEMONSTRATES HIGH REMISSION RATES IN PEDIATRIC PATIENTS WITH HIGH-RISK R/R B-ALL WITH OVERAL...
Více zde

ERNEXA THERAPEUTICS PRESENTS NEW PRECLINICAL DATA AT AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING ON LEAD CELL THERAPY CANDIDATE FOR TREATMENT OF OVARIAN CANCER

08-12-2025
POSITIVE RESULTS OF ERNA-101 IN OVARIAN CANCER MODELS DEMONSTRATED PROMISING SURVIVAL BENEFIT AND IM...
Více zde

BIOINVENT PRESENTS IMPRESSIVE RESPONSE DATA FROM ONGOING PHASE 2A TRIAL OF TRIPLE COMBINATION BI-1206, RITUXIMAB, AND CALQUENCE IN R/R NHL AT ASH 2025

08-12-2025
EARLY DATA INDICATE THAT BI-1206 HAS THE POTENTIAL TO RESET ONE OF THE MAIN RESISTANCE MECHANISMS TO...
Více zde

NURIX THERAPEUTICS PRESENTS NEW DATA FROM THE PHASE 1 TRIAL OF BEXOBRUTIDEG (NX-5948) IN WALDENSTRÖM MACROGLOBULINEMIA AT THE 67TH AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING AND EXPOSITION

08-12-2025
OBJECTIVE RESPONSE RATE (ORR) OF 75.0% INCLUDING THREE VERY GOOD PARTIAL RESPONSES (VGPR) IN HEAVILY...
Více zde

SYNDAX HIGHLIGHTS LEADERSHIP IN MENIN INHIBITION AT ASH 2025 WITH MULTIPLE REVUFORJ® (REVUMENIB) PRESENTATIONS SPANNING THE ACUTE LEUKEMIA TREATMENT CONTINUUM

08-12-2025
– FIRST REAL-WORLD EVIDENCE FOR A MENIN INHIBITOR SHOWS 77% ORR (10/13), 31% (4/13) CR/CRH, 75% (9...
Více zde

ASH 2025: CELLECTIS PRESENTS DEVELOPMENT PLAN TO FURTHER ENHANCE HIGH RESPONSE RATE OBSERVED FOR ETI-CEL IN R/R NHL

08-12-2025
NEW YORK, DEC. 08, 2025 (GLOBE NEWSWIRE) -- CELLECTIS (THE “COMPANY”) (EURONEXT GROWTH: ALCLS ...
Více zde

ASH 2025 | ASCENTAGE PHARMA PRESENTS ENCOURAGING DATA FROM PHASE IB/II STUDY OF BCL-2 INHIBITOR LISAFTOCLAX IN VENETOCLAX–EXPOSED PATIENTS WITH MYELOID MALIGNANCES

07-12-2025
ROCKVILLE, MD. AND SUZHOU, CHINA, DEC. 07, 2025 (GLOBE NEWSWIRE) -- ASCENTAGE PHARMA GROUP INTERNATI...
Více zde

ASH 2025 ORAL PRESENTATION: INNOVENT BIOLOGICS ANNOUNCES INITIAL RESULTS OF THE FIRST-IN-HUMAN PHASE 1 STUDY OF TRISPECIFIC ANTIBODY IBI3003 IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

07-12-2025
SAN FRANCISCO AND SUZHOU, CHINA , DEC. 7, 2025 /PRNEWSWIRE/ -- INNOVENT BIOLOGICS, INC. ("INNOVENT")...
Více zde

AT ASH 2025 ORAL PRESENTATION, IMMIX BIOPHARMA REPORTS POSITIVE PHASE 2 NXC-201 RESULTS, ADVANCING TOWARD BLA SUBMISSION AS A POTENTIALLY FIRST- AND BEST-IN-CLASS THERAPY FOR RELAPSED/REFRACTORY AL AMYLOIDOSIS

07-12-2025
– NXC-201 DEMONSTRATED A COMPLETE RESPONSE (CR) RATE OF 75% (15/20) (AT S/U IFE(-) LEVEL) BY INDEP...
Více zde

SONROTOCLAX DATA AT ASH 2025 CONFIRM FOUNDATIONAL POTENTIAL ACROSS B-CELL MALIGNANCIES

07-12-2025
SAN CARLOS, CALIF.--(BUSINESS WIRE)---- $ONC #BEONE--BEONE MEDICINES LTD. (NASDAQ: ONC; HKEX: 06160;...
Více zde

LYELL IMMUNOPHARMA PRESENTS NEW CLINICAL DATA FROM ONGOING TRIAL OF RONDE-CEL SHOWING HIGH RATES OF DURABLE COMPLETE RESPONSES IN PATIENTS WITH LARGE B-CELL LYMPHOMA AT THE 67TH ASH ANNUAL MEETING AND EXPOSITION

07-12-2025
SOUTH SAN FRANCISCO, CALIF., DEC. 07, 2025 (GLOBE NEWSWIRE) -- LYELL IMMUNOPHARMA, INC. (NASDAQ: LYE...
Více zde

RIGEL PRESENTS UPDATED DATA FROM THE ONGOING PHASE 1B STUDY EVALUATING R289 IN PATIENTS WITH LOWER-RISK MDS AT THE 67TH ASH ANNUAL MEETING AND EXPOSITION

07-12-2025
R289 CONTINUES TO BE GENERALLY WELL TOLERATED AND AT DOSES OF ≥500 MG QD PRELIMINARY EFFICACY WAS ...
Více zde

YESCARTA® DELIVERS CONSISTENT SAFETY, EFFICACY, AND QUALITY OF LIFE BENEFITS ACROSS BROAD RANGE OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA PATIENTS IN NEW ANALYSIS AT ASH 2025

07-12-2025
SANTA MONICA, CALIF.--(BUSINESS WIRE)--KITE, A GILEAD COMPANY (NASDAQ: GILD), PRESENTED A NEW ANALYS...
Více zde

KITE ANNOUNCES NEW DATA FOR PIVOTAL IMMAGINE-1 STUDY AT ASH 2025, HIGHLIGHTING ANITO-CEL'S OPPORTUNITY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

06-12-2025
SANTA MONICA, CALIF.--(BUSINESS WIRE)--KITE, A GILEAD COMPANY (NASDAQ: GILD), AND ITS PARTNER ARCELL...
Více zde

PRELUDE THERAPEUTICS PRESENTS DATA AT THE 2025 ASH ANNUAL MEETING FROM ITS MYELOPROLIFERATIVE NEOPLASM (MPN) PROGRAMS

06-12-2025
FIRST DISCLOSURE OF PRT12396, A JAK2V617F-SELECTIVE JH2 INHIBITOR DEMONSTRATES DISEASE MODIFYING POT...
Více zde

ASCENTAGE PHARMA PRESENTS PIVOTAL CHINA REGISTRATIONAL STUDY DATA FOR LISAFTOCLAX IN ORAL REPORT AT 2025 AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING

06-12-2025
ROCKVILLE, MD. AND SUZHOU, CHINA, DEC. 06, 2025 (GLOBE NEWSWIRE) -- ASCENTAGE PHARMA GROUP INTERNATI...
Více zde

DECIPHERA ANNOUNCES ORAL PRESENTATION OF POSITIVE TOPLINE RESULTS FROM PHASE 2A STUDY OF SAPABLURSEN IN POLYCYTHEMIA VERA AT THE 67TH AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING

06-12-2025
OSAKA, JAPAN & WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, A MEMBER OF ONO PHARMACEU...
Více zde

ADAPTIVE BIOTECHNOLOGIES SHOWCASES LEADERSHIP IN HEMATOLOGY-ONCOLOGY MRD WITH NEW CLONOSEQ® DATA DRIVING TREATMENT INTERVENTIONS AT 2025 ASH ANNUAL MEETING

06-12-2025
SEATTLE, DEC. 06, 2025 (GLOBE NEWSWIRE) -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (NASDAQ: ADPT), A CO...
Více zde

APTOSE'S TUSPETINIB TRIPLE DRUG THERAPY FEATURED AT THE 2025 ASH ANNUAL MEETING; HIGH RATE OF FRONTLINE CLINICAL RESPONSES CONTINUES ACROSS AML POPULATIONS

06-12-2025
APTOSE'S TUSPETINIB TRIPLE DRUG THERAPY FEATURED AT 2025 ASH ANNUAL MEETING; HIGH RATE OF FRONTLINE ...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-03 00:00:0010-QStáhnout
2026-02-02 00:00:008-KStáhnout
2026-01-27 00:00:008-KStáhnout
2026-01-22 00:00:008-KStáhnout
2025-11-20 00:00:0010-KStáhnout
2025-11-04 00:00:008-KStáhnout
2025-09-18 01:00:008-KStáhnout
2025-09-18 00:00:008-KStáhnout
2025-07-30 01:00:0010-QStáhnout
2025-07-30 00:00:0010-QStáhnout
2025-07-29 01:00:008-KStáhnout
2025-07-29 00:00:008-KStáhnout
2025-07-21 01:00:008-KStáhnout
2025-07-21 00:00:008-KStáhnout
2025-07-14 01:00:008-KStáhnout
2025-07-14 00:00:008-KStáhnout
2025-05-05 01:00:008-KStáhnout
2025-05-05 00:00:008-KStáhnout
2025-05-01 01:00:0010-QStáhnout
2025-05-01 00:00:0010-QStáhnout
2025-04-30 01:00:008-KStáhnout
2025-04-30 00:00:008-KStáhnout
2025-01-29 00:00:0010-QStáhnout
2025-01-28 23:00:0010-QStáhnout
2025-01-28 00:00:008-KStáhnout
2025-01-27 23:00:008-KStáhnout
2025-01-22 00:00:008-KStáhnout
2025-01-21 23:00:008-KStáhnout
2024-11-25 00:00:008-KStáhnout
2024-11-24 23:00:008-KStáhnout
2024-11-18 00:00:0010-KStáhnout
2024-11-17 23:00:0010-KStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-05 23:00:008-KStáhnout
2024-11-05 00:00:008-KStáhnout
2024-11-04 23:00:008-KStáhnout
2024-09-16 01:00:008-KStáhnout
2024-09-16 00:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-01 01:00:0010-QStáhnout
2024-05-01 00:00:0010-QStáhnout
2024-04-30 01:00:008-KStáhnout
2024-04-30 00:00:008-KStáhnout
2024-04-15 01:00:008-KStáhnout
2024-04-15 00:00:008-KStáhnout
2024-02-26 00:00:008-KStáhnout
2024-02-25 23:00:008-KStáhnout
2024-01-31 00:00:0010-QStáhnout
2024-01-30 23:00:0010-QStáhnout
2024-01-30 00:00:008-KStáhnout
2024-01-29 23:00:008-KStáhnout
2024-01-26 00:00:008-KStáhnout
2024-01-25 23:00:008-KStáhnout
2023-11-17 00:00:008-KStáhnout
2023-11-17 00:00:0010-KStáhnout
2023-11-16 23:00:008-KStáhnout
2023-11-16 23:00:0010-KStáhnout
2023-11-14 00:00:008-KStáhnout
2023-11-13 23:00:008-KStáhnout
2023-11-08 00:00:008-KStáhnout
2023-11-07 23:00:008-KStáhnout
2023-11-01 00:00:008-KStáhnout
2023-10-31 23:00:008-KStáhnout
2023-10-24 01:00:008-KStáhnout
2023-10-24 00:00:008-KStáhnout
2023-08-16 01:00:008-KStáhnout
2023-08-16 00:00:008-KStáhnout
2023-07-27 01:00:0010-QStáhnout
2023-07-27 00:00:0010-QStáhnout
2023-07-25 01:00:008-KStáhnout
2023-07-25 00:00:008-KStáhnout
2023-06-28 01:00:008-KStáhnout
2023-06-28 00:00:008-KStáhnout
2023-06-26 01:00:008-KStáhnout
2023-06-26 00:00:008-KStáhnout
2023-05-12 01:00:008-KStáhnout
2023-05-12 00:00:008-KStáhnout
2023-05-03 01:00:0010-QStáhnout
2023-05-03 00:00:0010-QStáhnout
2023-05-02 01:00:008-KStáhnout
2023-05-02 00:00:008-KStáhnout
2023-04-20 01:00:008-KStáhnout
2023-04-20 00:00:008-KStáhnout
2023-02-01 00:00:0010-QStáhnout
2023-01-31 23:00:0010-QStáhnout
2023-01-31 00:00:008-KStáhnout
2023-01-30 23:00:008-KStáhnout
2023-01-27 00:00:008-KStáhnout
2023-01-26 23:00:008-KStáhnout
2023-01-25 00:00:008-KStáhnout
2023-01-24 23:00:008-KStáhnout
2022-11-21 00:00:0010-KStáhnout
2022-11-20 23:00:0010-KStáhnout
2022-11-07 00:00:008-KStáhnout
2022-11-06 23:00:008-KStáhnout
2022-09-20 01:00:008-KStáhnout
2022-09-20 00:00:008-KStáhnout
2022-09-14 01:00:008-KStáhnout
2022-09-14 00:00:008-KStáhnout
2022-08-01 01:00:008-KStáhnout
2022-08-01 00:00:008-KStáhnout
2022-07-28 01:00:0010-QStáhnout
2022-07-28 00:00:0010-QStáhnout
2022-07-26 01:00:008-KStáhnout
2022-07-26 00:00:008-KStáhnout
2022-07-22 01:00:008-KStáhnout
2022-07-22 00:00:008-KStáhnout
2022-07-18 01:00:008-KStáhnout
2022-07-18 00:00:008-KStáhnout
2022-06-10 01:00:008-KStáhnout
2022-06-10 00:00:008-KStáhnout
2022-06-09 01:00:008-KStáhnout
2022-06-09 00:00:008-KStáhnout
2022-05-26 01:00:008-KStáhnout
2022-05-26 00:00:008-KStáhnout
2022-05-20 01:00:008-KStáhnout
2022-05-20 00:00:008-KStáhnout
2022-04-28 01:00:0010-QStáhnout
2022-04-28 00:00:0010-QStáhnout
2022-04-26 01:00:008-KStáhnout
2022-04-26 00:00:008-KStáhnout
2022-04-12 01:00:008-KStáhnout
2022-04-12 00:00:008-KStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-02-24 00:00:008-KStáhnout
2022-02-23 23:00:008-KStáhnout
2022-02-03 00:00:0010-QStáhnout
2022-02-02 23:00:0010-QStáhnout
2022-02-01 00:00:008-KStáhnout
2022-01-31 23:00:008-KStáhnout
2022-01-27 00:00:008-KStáhnout
2022-01-26 23:00:008-KStáhnout
2022-01-18 00:00:008-KStáhnout
2022-01-17 23:00:008-KStáhnout
2021-11-22 00:00:0010-KStáhnout
2021-11-21 23:00:0010-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-01 00:00:008-KStáhnout
2021-10-31 23:00:008-KStáhnout
2021-09-27 01:00:008-KStáhnout
2021-09-27 00:00:008-KStáhnout
2021-09-08 01:00:008-KStáhnout
2021-09-08 00:00:008-KStáhnout
2021-09-07 01:00:008-KStáhnout
2021-09-07 00:00:008-KStáhnout
2021-08-31 01:00:008-KStáhnout
2021-08-31 00:00:008-KStáhnout
2021-08-18 01:00:008-KStáhnout
2021-08-18 00:00:008-KStáhnout
2021-08-06 01:00:008-KStáhnout
2021-08-06 00:00:008-KStáhnout
2021-08-03 01:00:008-KStáhnout
2021-08-03 00:00:008-KStáhnout
2021-07-29 01:00:0010-QStáhnout
2021-07-29 00:00:0010-QStáhnout
2021-07-27 01:00:008-KStáhnout
2021-07-27 00:00:008-KStáhnout
2021-06-10 01:00:008-KStáhnout
2021-06-10 00:00:008-KStáhnout
2021-05-25 01:00:008-KStáhnout
2021-05-25 00:00:008-KStáhnout
2021-04-30 01:00:008-KStáhnout
2021-04-30 00:00:008-KStáhnout
2021-04-29 01:00:0010-QStáhnout
2021-04-29 00:00:0010-QStáhnout
2021-04-28 01:00:008-KStáhnout
2021-04-28 00:00:008-KStáhnout
2021-03-18 00:00:008-KStáhnout
2021-03-17 23:00:008-KStáhnout
2021-02-04 00:00:0010-QStáhnout
2021-02-03 23:00:0010-QStáhnout
2021-02-03 00:00:008-KStáhnout
2021-02-02 23:00:008-KStáhnout
2021-01-22 00:00:008-KStáhnout
2021-01-21 23:00:008-KStáhnout
2021-01-19 00:00:008-KStáhnout
2021-01-18 23:00:008-KStáhnout
2020-11-23 00:00:0010-KStáhnout
2020-11-22 23:00:0010-KStáhnout
2020-11-10 00:00:008-KStáhnout
2020-11-09 23:00:008-KStáhnout
2020-10-01 01:00:008-KStáhnout
2020-10-01 00:00:008-KStáhnout
2020-07-30 01:00:0010-QStáhnout
2020-07-30 00:00:0010-QStáhnout
2020-07-28 01:00:008-KStáhnout
2020-07-28 00:00:008-KStáhnout
2020-07-27 01:00:008-KStáhnout
2020-07-27 00:00:008-KStáhnout
2020-07-17 01:00:008-KStáhnout
2020-07-17 00:00:008-KStáhnout
2020-05-22 01:00:008-KStáhnout
2020-05-22 00:00:008-KStáhnout
2020-05-06 01:00:0010-QStáhnout
2020-05-06 00:00:0010-QStáhnout
2020-05-05 01:00:008-KStáhnout
2020-05-05 00:00:008-KStáhnout
2020-04-28 01:00:008-KStáhnout
2020-04-28 00:00:008-KStáhnout
2020-04-16 01:00:008-KStáhnout
2020-04-16 00:00:008-KStáhnout
2020-02-04 00:00:008-KStáhnout
2020-02-03 23:00:008-KStáhnout
2020-01-31 00:00:008-KStáhnout
2020-01-30 23:00:008-KStáhnout
2020-01-29 00:00:0010-QStáhnout
2020-01-28 23:00:0010-QStáhnout
2020-01-27 00:00:008-KStáhnout
2020-01-26 23:00:008-KStáhnout
2020-01-23 00:00:008-KStáhnout
2020-01-22 23:00:008-KStáhnout
2020-01-10 00:00:008-KStáhnout
2020-01-09 23:00:008-KStáhnout
2020-01-09 00:00:008-KStáhnout
2020-01-08 23:00:008-KStáhnout
2020-01-07 00:00:008-KStáhnout
2020-01-06 23:00:008-KStáhnout
2019-12-18 00:00:008-KStáhnout
2019-12-17 23:00:008-KStáhnout
2019-12-17 00:00:008-KStáhnout
2019-12-16 23:00:008-KStáhnout
2019-12-09 00:00:008-KStáhnout
2019-12-08 23:00:008-KStáhnout
2019-11-25 00:00:0010-KStáhnout
2019-11-24 23:00:0010-KStáhnout
2019-11-18 00:00:008-KStáhnout
2019-11-17 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-11 23:00:008-KStáhnout
2019-10-08 01:00:008-KStáhnout
2019-10-08 00:00:008-KStáhnout
2019-09-03 01:00:008-KStáhnout
2019-09-03 00:00:008-KStáhnout
2019-08-14 01:00:008-KStáhnout
2019-08-14 00:00:008-KStáhnout
2019-08-02 01:00:008-KStáhnout
2019-08-02 00:00:008-KStáhnout
2019-07-31 01:00:0010-QStáhnout
2019-07-31 00:00:0010-QStáhnout
2019-07-30 01:00:008-KStáhnout
2019-07-30 00:00:008-KStáhnout
2019-07-17 01:00:008-KStáhnout
2019-07-17 00:00:008-KStáhnout
2019-07-08 01:00:008-KStáhnout
2019-07-08 00:00:008-KStáhnout
2019-05-22 01:00:008-KStáhnout
2019-05-22 00:00:008-KStáhnout
2019-05-07 01:00:008-KStáhnout
2019-05-07 00:00:008-KStáhnout
2019-05-01 01:00:0010-QStáhnout
2019-05-01 00:00:0010-QStáhnout
2019-04-30 01:00:008-KStáhnout
2019-04-30 00:00:008-KStáhnout
2019-04-29 01:00:008-KStáhnout
2019-04-29 00:00:008-KStáhnout
2019-02-13 00:00:008-KStáhnout
2019-02-12 23:00:008-KStáhnout
2019-02-06 00:00:0010-QStáhnout
2019-02-05 23:00:0010-QStáhnout
2019-02-05 00:00:008-KStáhnout
2019-02-04 23:00:008-KStáhnout
2019-01-22 00:00:008-KStáhnout
2019-01-21 23:00:008-KStáhnout
2019-01-14 00:00:008-KStáhnout
2019-01-13 23:00:008-KStáhnout
2018-12-27 00:00:008-KStáhnout
2018-12-26 23:00:008-KStáhnout
2018-11-20 00:00:008-KStáhnout
2018-11-19 23:00:008-KStáhnout
2018-11-19 00:00:0010-KStáhnout
2018-11-18 23:00:0010-KStáhnout
2018-11-15 00:00:008-KStáhnout
2018-11-14 23:00:008-KStáhnout
2018-11-06 00:00:008-KStáhnout
2018-11-05 23:00:008-KStáhnout
2018-08-01 01:00:0010-QStáhnout
2018-08-01 00:00:0010-QStáhnout
2018-07-31 01:00:008-KStáhnout
2018-07-31 00:00:008-KStáhnout
2018-07-02 01:00:008-KStáhnout
2018-07-02 00:00:008-KStáhnout
2018-05-23 01:00:008-KStáhnout
2018-05-23 00:00:008-KStáhnout
2018-05-17 01:00:008-KStáhnout
2018-05-17 00:00:008-KStáhnout
2018-05-02 01:00:0010-QStáhnout
2018-05-02 00:00:0010-QStáhnout
2018-05-01 01:00:008-KStáhnout
2018-05-01 00:00:008-KStáhnout
2018-03-20 00:00:008-KStáhnout
2018-03-19 23:00:008-KStáhnout
2018-01-30 00:00:0010-QStáhnout
2018-01-29 23:00:0010-QStáhnout
2018-01-29 00:00:008-KStáhnout
2018-01-28 23:00:008-KStáhnout
2018-01-26 00:00:008-KStáhnout
2018-01-25 23:00:008-KStáhnout
2017-11-28 00:00:008-KStáhnout
2017-11-27 23:00:008-KStáhnout
2017-11-20 00:00:0010-KStáhnout
2017-11-19 23:00:0010-KStáhnout
2017-11-17 00:00:008-KStáhnout
2017-11-16 23:00:008-KStáhnout
2017-11-06 00:00:008-KStáhnout
2017-11-05 23:00:008-KStáhnout
2017-09-18 01:00:008-KStáhnout
2017-09-18 00:00:008-KStáhnout
2017-09-01 01:00:008-KStáhnout
2017-09-01 00:00:008-KStáhnout
2017-08-23 01:00:008-KStáhnout
2017-08-23 00:00:008-KStáhnout
2017-08-11 01:00:008-KStáhnout
2017-08-11 00:00:008-KStáhnout
2017-08-04 01:00:0010-QStáhnout
2017-08-04 00:00:0010-QStáhnout
2017-08-01 01:00:008-KStáhnout
2017-08-01 00:00:008-KStáhnout
2017-07-19 01:00:008-KStáhnout
2017-07-19 00:00:008-KStáhnout
2017-06-14 01:00:008-KStáhnout
2017-06-14 00:00:008-KStáhnout
2017-05-22 01:00:008-KStáhnout
2017-05-22 00:00:008-KStáhnout
2017-05-18 01:00:008-KStáhnout
2017-05-18 00:00:008-KStáhnout
2017-05-17 01:00:008-KStáhnout
2017-05-17 00:00:008-KStáhnout
2017-05-15 01:00:008-KStáhnout
2017-05-15 00:00:008-KStáhnout
2017-05-12 01:00:008-KStáhnout
2017-05-12 00:00:008-KStáhnout
2017-05-08 01:00:008-KStáhnout
2017-05-08 00:00:008-KStáhnout
2017-05-01 01:00:008-KStáhnout
2017-05-01 00:00:008-KStáhnout
2017-04-26 01:00:0010-QStáhnout
2017-04-26 00:00:0010-QStáhnout
2017-04-25 01:00:008-KStáhnout
2017-04-25 00:00:008-KStáhnout
2017-04-17 01:00:008-KStáhnout
2017-04-17 00:00:008-KStáhnout
2017-03-27 01:00:008-KStáhnout
2017-03-27 00:00:008-KStáhnout
2017-02-21 00:00:008-KStáhnout
2017-02-20 23:00:008-KStáhnout
2017-01-30 00:00:008-KStáhnout
2017-01-29 23:00:008-KStáhnout
2017-01-27 00:00:0010-QStáhnout
2017-01-26 23:00:0010-QStáhnout
2017-01-26 00:00:008-KStáhnout
2017-01-25 23:00:008-KStáhnout
2016-11-28 00:00:008-KStáhnout
2016-11-27 23:00:008-KStáhnout
2016-11-21 00:00:0010-KStáhnout
2016-11-20 23:00:0010-KStáhnout
2016-11-08 00:00:008-KStáhnout
2016-11-07 23:00:008-KStáhnout
2016-10-20 01:00:008-KStáhnout
2016-10-20 00:00:008-KStáhnout
2016-09-28 01:00:008-KStáhnout
2016-09-28 00:00:008-KStáhnout
2016-09-23 01:00:008-KStáhnout
2016-09-23 00:00:008-KStáhnout
2016-09-20 01:00:008-KStáhnout
2016-09-20 00:00:008-KStáhnout
preloader